National Brazilian survey on the outcomes of hepatitis c retreatment in patients non-responders to direct antiviral agents.

doi:10.1016/j.bjid.2022.102388

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

National Brazilian survey on the outcomes of hepatitis c retreatment in patients non-responders to direct antiviral agents.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases - 1 Jan 2000

Ferraz Maria Lúcia Gomes, Piccoli Leonora de Zorzi, Rezende Rosamar, Borba Luiz Augusto, Junior Alcindo Pissaia, Cheinquer Hugo, Silva Giovanni Faria, Ferreira Paulo Roberto Abrão, Villela-Nogueira Cristiane Alves, Mazo Daniel Ferraz, Souza Fernanda Fernandes, Codes Liana, Ivantes Claudia Alexandra Pontes, Gomide Geisa Perez Medina, Pereira Gustavo Henrique Santos, Pessôa Mário Guimarães, França Alex Vianey Callado, Pinto Arlene Dos Santos, Teixeira Rosângela, Bittencourt Paulo Lisboa

Abstract excerpt

BACKGROUND AND AIMS: Treatment of hepatitis C with direct antiviral agents (DAA) is associated with almost 95% of sustained virological response. However, some patients need retreatment. In Brazil, it should be done according to the Ministry of Health guidelines, frequently updated to include newly available drugs. This study aimed to conduct a national survey about the characteristics and outcomes of retreatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbamates

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Hepatitis C

Share to Hepatitis C, Chronic

Source

Open in PubMed Open full text

Identifiers

PMID: 35905930
DOI: 10.1016/j.bjid.2022.102388
PMCID: PMC9459029

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

National Brazilian survey on the outcomes of hepatitis c retreatment in patients non-responders to direct antiviral agents.PMID 35905930Read ↗

Treatment of Chronic HCV Infection with the New Direct Acting Antivirals (DAA): First Report of a Real World Experience in Southern Brazil.Semantic proximity Read ↗

A Real-life Study of the Positive Response to DAA-based Therapies for Hepatitis C in BrazilSemantic proximity Read ↗

Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil.Semantic proximity Read ↗

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort.Semantic proximity Read ↗

Changes in the response to treatment against chronic hepatitis C between 1999 and 2015: data from a prospective cohort.Semantic proximity Read ↗

Efficacy of Second Generation Direct-Acting Antiviral Agents for Treatment Naïve Hepatitis C Genotype 1: A Systematic Review and Network Meta-Analysis.Semantic proximity Read ↗

Direct-acting antiviral agents in patients with hepatitis C genotype 1-4 infections in a tertiary hospital.Semantic proximity Read ↗

Treatment of chronic HCV infection with DAAs in Rio de Janeiro/Brazil: SVR rates and baseline resistance analyses in NS5A and NS5B genesSemantic proximity Read ↗

Outcome of hepatitis C patients in a community with predominant genotype 3 with standard-of-care treatment before and after advent of direct-acting antivirals: A retrospective-cum-prospective study.Semantic proximity Read ↗

Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV).Semantic proximity Read ↗

Experience with direct-acting antivirals in genotype 1-5 infected chronic hepatitis C patients in Turkey.Semantic proximity Read ↗

Treatment of HCV infection with direct-acting antiviral agents. Real life experiences from the Euro-Asian region.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.